Best therapy for the easiest to treat hepatitis C virus genotype 1b-infected patients

BACKGROUND: The revolution in treatment of patients with chronic hepatitis C virus (HCV) infection dates back to the introduction of direct-acting antivirals (DAAs). The increase in efficacy was most pronounced in patients infected with genotype (GT) 1b, as this was the most poorly responsive popula...

Descripción completa

Detalles Bibliográficos
Autores principales: Zarębska-Michaluk, Dorota, Brzdęk, Michał, Jaroszewicz, Jerzy, Tudrujek-Zdunek, Magdalena, Lorenc, Beata, Klapaczyński, Jakub, Mazur, Włodzimierz, Kazek, Adam, Sitko, Marek, Berak, Hanna, Janocha-Litwin, Justyna, Dybowska, Dorota, Supronowicz, Łukasz, Krygier, Rafał, Citko, Jolanta, Piekarska, Anna, Flisiak, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753050/
https://www.ncbi.nlm.nih.gov/pubmed/36533109
http://dx.doi.org/10.3748/wjg.v28.i45.6380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753050/
https://www.ncbi.nlm.nih.gov/pubmed/36533109
http://dx.doi.org/10.3748/wjg.v28.i45.6380

Ejemplares similares